Using the PD-L1 inhibitor durvalumab with neoadjuvant cisplatin/gemcitabine chemotherapy and continuing using it as adjuvant therapy after radical surgery could achieve high rates of event-free survival and downstaging, new findings show.
Physician bias in clinical reasoning, lack of empathy, and inadequate communication skills can give patients a sense that their health issues are being dismissed or ignored.
Investigators assessed the predictive value of estimated glucose disposal rate on renal outcomes among patients with type 2 diabetes mellitus.
Researchers sought to determine the age-adjusted mortality rates related to cancer in US counties.
Model predicts overall and heart failure hospitalization-free survival and treatment benefit in HFrEF
Side effect (ileus) is also listed on labels for the weight-loss drug Wegovy and the diabetes medication Mounjaro
However, consumption varies significantly by condition
Safety concerns to consider for youth with diabetes who are restricting carbohydrates include growth deceleration, poor bone health
Findings seen for people with or without type 2 diabetes, but similar trend not seen for those with type 1 diabetes
Waist-to-hip ratio has stronger association with mortality than BMI, particularly in men
